Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSİVE CARE PATIENTS UNDER MECHANICVENTILATION SUPPORT

2. juni 2026 opdateret af: MELTEM KALAYCI, Hasan Kalyoncu University

THE EFFECT OF SU-JOK THERAPY APPLIED TO INTENSIVE CARE PATIENTS UNDER MECHANICAL VENTILATION SUPPORT ON PAIN AND PHYSIOLOGICAL PARAMETERS.

The aim of this study is to examine the effect of Su Jok Therapy, applied to patients receiving mechanical ventilation support in the intensive care unit, on pain and physiological parameters.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Mechanical ventilation (MV), one of the most common treatment methods in Intensive Care Units (ICUs), is a critical treatment approach to ensure adequate respiratory function in patients.

Although mechanical ventilation is a life-saving treatment method in ICUs, it can cause many physiological and psychological problems for patients. Furthermore, excessive exposure to physical, psychosocial, and environmental stressors can affect the patient's autonomic response and vital parameters (tachycardia, hypertension, tachypnea), leading to hemodynamic instability

The World Health Organization (WHO) defines Integrated, Complementary, and Alternative Medicine Practices as the provision of healthcare services that are not part of a country's own tradition or conventional medicine and are not fully integrated into the dominant healthcare system In intensive care patients, non-pharmacological methods such as aromatherapy, music therapy, massage, reflexology, acupressure, and Reiki are used as complementary and alternative treatments. Su Jok, one of these non-pharmacological methods, is an alternative treatment method based on traditional Korean medicine. Su Jok is a treatment method that uses the feet and hands, derived from the Korean words Su (hand) and Jok (foot). In the literature, it is argued that nurses can apply Su Jok therapy as an integrative method in symptom management due to its simplicity of application, lack of side effects, and non-invasiveness, which is similar to the philosophy of integrative nursing. Looking at the literature, very few studies on Su Jok therapy have been found. No studies have been found in the literature regarding the effect of Su Jok therapy on intensive care patients and patients on mechanical ventilation support.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

30

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Tyrkiet (Türkiye)
    • Kahramanmaraş
      • Kahramanmaraş, Kahramanmaraş, Tyrkiet (Türkiye), 46050
        • Kahramanmaraş

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Patients who are in intensive care,

    • Patients receiving IMV support,
    • Patients who were admitted to the ICU from the start date of the study and are planned to be monitored for at least 24 hours,
    • Patients without any problems in the area where Su-Jok will be applied,
    • Patients with GCS > 3, RASS between +1 and +4, BPS > 3

Exclusion Criteria:

  • • Patients in the ward,

    • Patients with any problems such as fungal infections or wounds in the area where Su Jok will be applied,
    • Patients with a GCS of 3,
    • Patients not receiving IMV support will not be included in the study.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Ingen indgriben: Kontrolgruppe
Ingen intervention vil blive anvendt til kontrolgruppen.
Eksperimentel: Intervetion group
In the intervention group, su-jok seed therapy will be applied to the su-jok reflection zones on the hands.
Andet: su jok therapy group
In the intervention group, the reflex zones on the hands were identified with a probe. Buckwheat seeds were fixed to these areas with adhesive tape and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.
Placebo komparator: Placebo group
In the placebo group, su-jok seed therapy will be applied to areas on the hands that are different from the reflection zones.
Andet: Placebo Group
In the placebo group, reflex zones on the hand were identified using a probe. Buckwheat seeds were fixed to a different area near these zones with a seed patch and massaged. The seeds remained in place for 4 hours. After 2 hours, these areas were stimulated with a 1-2 minute massage. Measurements were recorded on a data collection form. The application was carried out for 3 days.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Systolic Blood Pressure
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Hemodynamic response measured by systolic blood pressure
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart Rate (Pulse Rate)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart rate measured in beats per minute
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Oxygen Saturation (SpO₂)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Peripheral oxygen saturation
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Body Temperature
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Core body temperature
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Respiratory Rate
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Number of breaths per minute
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Richmond Agitation-Sedation Scale (RASS)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Negative scores indicate sedation, positive scores indicate agitation
baseline, 1 hour, 4 hours after intervention
Behavioral Pain Scale (BPS)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Higher scores indicate more severe pain
baseline, 1 hour, 4 hours after intervention

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Hemodynamic Stability Index (Systolic/Diastolic Blood Pressure Change)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Change in systolic and diastolic blood pressure from baseline to post-intervention measurements.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Oxygenation Trend (SpO₂ Change Over Time)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
hanges in peripheral oxygen saturation over the intervention period.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Heart Rate Variability (Clinical Pulse Trend)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Changes in heart rate measured in beats per minute during and after intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Sedation-Agitation Level Stability (RASS Trend)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Changes in Richmond Agitation-Sedation Scale (RASS) scores over time indicating sedation or agitation level.
baseline, 1 hour, 4 hours after intervention
Pain Intensity Change (Behavioral Pain Scale Trend)
Tidsramme: baseline, 1 hour, 4 hours after intervention
Changes in Behavioral Pain Scale (BPS) scores indicating pain severity over time.
baseline, 1 hour, 4 hours after intervention
Respiratory Stability (Respiratory Rate Change)
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
Changes in respiratory rate indicating respiratory stability during intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Temperature Stability
Tidsramme: baseline, 15 minutes, 60 minutes, 4 hours after intervention
hanges in body temperature over time following intervention.
baseline, 15 minutes, 60 minutes, 4 hours after intervention
Non-pharmacological Intervention Effectiveness (Overall Clinical Stability Score)
Tidsramme: baseline, 4 hours after intervention
Composite assessment of physiological stability based on vital signs and sedation/pain scores.
baseline, 4 hours after intervention

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Hasan Kalyoncu University

Efterforskere

  • Studiestol: NERMİN OLGUN, Prof. Dr., Hasan Kalyoncu University
  • Ledende efterforsker: MELTEM KALAYCI, Hasan Kalyoncu University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. marts 2025

Primær færdiggørelse (Faktiske)

1. marts 2025

Studieafslutning (Faktiske)

1. november 2025

Datoer for studieregistrering

Først indsendt

30. december 2025

Først indsendt, der opfyldte QC-kriterier

2. juni 2026

Først opslået (Faktiske)

8. juni 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

8. juni 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

2. juni 2026

Sidst verificeret

1. juni 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • HKU-LEE-MK-01

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Patienter på intensiv afdeling

Kliniske forsøg med su jok therapy group

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Canada

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner